Release and Cytocompatibility Study of New Hybrid Materials Based on Ferulic Acid for Biomedical Use

基于阿魏酸的新型杂化材料的释放和细胞相容性研究及其在生物医学领域的应用

阅读:2

Abstract

In recent years, research into the synthesis of innovative biomaterials for prosthetic applications has been increasingly growing. In particular, there is a demand for biomaterials with an excellent biocompatibility that can interact with biological fluids. This study involved the development of new silica (SiO(2))-based composite materials using the sol-gel technique and functionalization with ferulic acid (FA), a natural phenolic compound renowned for its biological properties. The synthesis involved controlling the hydrolysis and condensation of tetraethyl orthosilicate (TEOS) in acidic and alcoholic environments to incorporate ferulic acid into the sol phase matrix at different weight compositions (5, 10, 15, and 20 wt%). Fourier transform infrared spectroscopy analyses (FTIR) confirmed the successful incorporation of the bioactive compound, and in vitro tests revealed a good cytocompatibility and controlled ferulic acid release over time. These results demonstrate that the developed material shows promise as a bioactive coating for orthopedic prostheses, improving bone integration and reducing undesirable post-operative phenomena.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。